This means every bottle of Prime Biome undergoes strict quality control, from ingredient sourcing to final product testing.

No serious complaints have been found regarding the quality of Prime Biome supplements. This is evident from examining the ...

The conference call can be accessed using the following information: Webcast: Click here Date: Tuesday, May 13, 2025 – 4:30 p.m. ET Domestic: (877) 407-0832 International: (201) 689-8433 Conference ID ...

EnteroBiotix Limited (‘EnteroBiotix’), a clinical-stage biopharmaceutical company focussed on developing best-in-class drugs for gut health, today announced that results from its IMPuLCE Phase 1b ...

Integration of Hapbee’s product line — including the Hapbee Sleep Pad, Hapbee Neckband, and soon-to-be-launched Immersive Mattress Topper — into Snooze’s wellness assortment, both in-store and online.

Vesting of the stock option is subject to such employee's continued service to Taysha on each vesting date. About Taysha Gene Therapies Taysha Gene Therapies (Nasdaq: TSHA) is a clinical-stage ...

Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “We are pleased to appoint Arvind as the Interim CFO of SS Innovations. He is a seasoned ...

A live webcast of the Company’s fireside chat will be available from the “Investors & Media” section of ProQR’s website under “Events”. A replay of the webcast will then be available for approximately ...

Praxis reported a net loss of $69.3 million for the three months ended March 31, 2025, including $8.8 million of stock-based compensation expense, compared to $39.6 million for the three months ended ...

Cartesian Therapeutics is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T entering Phase 3 clinical ...

VAMOS analysis highlights link between EVAF and reduced muscle quality Case series reports success with combination tesamorelin/GLP-1 receptor agonist therapy MONTREAL, May 02, 2025 (GLOBE NEWSWIRE) - ...

Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced ...